Use of Indocyanine Green in Robotic Prostate Surgeries
Primary Purpose
Prostate Cancer Adenocarcinoma, Erectile Dysfunction Following Radical Prostatectomy
Status
Not yet recruiting
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
using Indocyanine Green
Nerve-sparing robot-assisted laparoscopic radical prostatectomy
Sponsored by

About this trial
This is an interventional treatment trial for Prostate Cancer Adenocarcinoma focused on measuring erectile dysfunction and indocyanine green, radical prostatectomy and indocyanine green
Eligibility Criteria
Inclusion Criteria: Patients with low-intermediate risk prostate cancer Exclusion Criteria: Patients high risk prostate cancer
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Group using Indocyanine Green
The Indocyanine Green -unused group
Arm Description
Performing nerve-sparing robot-assisted laparoscopic radical prostatectomy by IV injecting of Indocyanine Green
Nerve-sparing robot-assisted laparoscopic radical prostatectomy without the use of Indocyanine Green
Outcomes
Primary Outcome Measures
Evaluation of erectile function.
Evaluation of erectile function after Nerve Sparing Robot Assisted Laparoscopic Radical Prostatectomy with and without the application of Indocyanine Green.Evaluation of surgical margin positivity after Nerve Sparing Robot Assisted Laparoscopic Radical Prostatectomy with and without the application of Indocyanine Green.
Both groups will evaluate their erectile function by completing the preoperative International Index of Erectile Function Every groups of participants will fill the International Index of Erectile Function -5 again after surgery in 3. -6. -9. -12 months.
The possible scores for the International Index of Erectile Function- 5 range from 0 to 30, and Erectile disfonction is classified into five categories based on the scores: severe (0-10), moderate (11-16), mild to moderate (17-21), mild (22-25), and no erectile disfonction (26-30).
Evaluation of surgical margin positivity
Postoperative surgical margin positivity will be compared in both groups according to the results of the postoperative pathology report. Surgical margin positivity in both groups will be evaluated as a percentage and it will be evaluated whether there is a significant difference between the two groups
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05960149
Brief Title
Use of Indocyanine Green in Robotic Prostate Surgeries
Official Title
Evaluation of the Effect of Intraoperative Indocyanine Green Use on Erectile Function and Surgical Margin Positivity in Patients Undergoing Nerve-Sparing Robot-Assisted Laparoscopic Radical Prostatectomy
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 30, 2023 (Anticipated)
Primary Completion Date
December 3, 2025 (Anticipated)
Study Completion Date
March 31, 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ankara University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Imaging of the vascular nerve bundle using Indocyanine Green
Detailed Description
Comparison of erectile function and surgical margin positivity after nerve-sparing robot-assisted laparoscopic radical prostatectomy surgery performed by imaging the vascular nerve bundle using Indocyanine Green with the results after nerve-sparing robot-assisted laparoscopic radical prostatectomy surgery without Indocyanine Green
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer Adenocarcinoma, Erectile Dysfunction Following Radical Prostatectomy
Keywords
erectile dysfunction and indocyanine green, radical prostatectomy and indocyanine green
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group using Indocyanine Green
Arm Type
Experimental
Arm Description
Performing nerve-sparing robot-assisted laparoscopic radical prostatectomy by IV injecting of Indocyanine Green
Arm Title
The Indocyanine Green -unused group
Arm Type
Experimental
Arm Description
Nerve-sparing robot-assisted laparoscopic radical prostatectomy without the use of Indocyanine Green
Intervention Type
Drug
Intervention Name(s)
using Indocyanine Green
Other Intervention Name(s)
IV Indocyanine Green injection
Intervention Description
Nerve-sparing robot-assisted laparoscopic radical prostatectomy using Indocyanine Green
Intervention Type
Procedure
Intervention Name(s)
Nerve-sparing robot-assisted laparoscopic radical prostatectomy
Intervention Description
Nerve-sparing robot-assisted laparoscopic radical prostatectomy without the use of Indocyanine Green
Primary Outcome Measure Information:
Title
Evaluation of erectile function.
Description
Evaluation of erectile function after Nerve Sparing Robot Assisted Laparoscopic Radical Prostatectomy with and without the application of Indocyanine Green.Evaluation of surgical margin positivity after Nerve Sparing Robot Assisted Laparoscopic Radical Prostatectomy with and without the application of Indocyanine Green.
Both groups will evaluate their erectile function by completing the preoperative International Index of Erectile Function Every groups of participants will fill the International Index of Erectile Function -5 again after surgery in 3. -6. -9. -12 months.
The possible scores for the International Index of Erectile Function- 5 range from 0 to 30, and Erectile disfonction is classified into five categories based on the scores: severe (0-10), moderate (11-16), mild to moderate (17-21), mild (22-25), and no erectile disfonction (26-30).
Time Frame
up to 12 months
Title
Evaluation of surgical margin positivity
Description
Postoperative surgical margin positivity will be compared in both groups according to the results of the postoperative pathology report. Surgical margin positivity in both groups will be evaluated as a percentage and it will be evaluated whether there is a significant difference between the two groups
Time Frame
Up to 12 months
10. Eligibility
Sex
Male
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients with low-intermediate risk prostate cancer
Exclusion Criteria:
Patients high risk prostate cancer
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Araz Musaev, Dr
Phone
+905364536276
Email
msyv.araz@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Araz Musaev
Organizational Affiliation
Ankara Universitry
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Use of Indocyanine Green in Robotic Prostate Surgeries
We'll reach out to this number within 24 hrs